Levetiracetam and Cross sensitivity reaction - a phase IV clinical study of FDA data

Summary:

Cross sensitivity reaction is reported as a side effect among people who take Levetiracetam (levetiracetam), especially for people who are female, 20-29 old, also take Lamotrigine, and have Urinary tract infection.

The phase IV clinical study analyzes which people have Cross sensitivity reaction when taking Levetiracetam. It is created by eHealthMe based on reports of 74,747 people who have side effects when taking Levetiracetam from the FDA, and is updated regularly.

What is Levetiracetam?

Levetiracetam has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 75,292 Levetiracetam users. Check the latest studies of Levetiracetam.

What is Cross sensitivity reaction?

Cross sensitivity reaction is found to be associated with 48 drugs and 139 conditions by eHealthMe. Check the latest studies of Cross sensitivity reaction.

On Jul, 11, 2026

74,747 people reported to have side effects when taking Levetiracetam.
Among them, 19 people (0.03%) have Cross sensitivity reaction.

Could Levetiracetam cause Cross sensitivity reaction?

Among these 19 people:

What is the gender of people who have Cross sensitivity reaction when taking Levetiracetam? *

female: 93.75 %
male: 6.25 %

What is the age of people who have Cross sensitivity reaction when taking Levetiracetam? *

What are other drugs people take besides Levetiracetam? *

What are other side effects people have besides Cross sensitivity reaction? *

Transaminases Increased: 6 people, 31.58%
Erythema Multiforme (a type of hypersensitivity reaction): 3 people, 15.79%
Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 2 people, 10.53%
Inflammatory Marker Increased: 1 person, 5.26%
Angioedema (rapid swelling of the dermis): 1 person, 5.26%
Arrhythmias (irregular heartbeat): 1 person, 5.26%
Aspartate Aminotransferase Increased: 1 person, 5.26%
C-Reactive Protein Increased: 1 person, 5.26%
Disease Recurrence: 1 person, 5.26%
Drug Eruption (adverse drug reaction of the skin): 1 person, 5.26%

What are the existing conditions these people have? *

Urinary Tract Infection: 2 people, 10.53%
Drug Eruption (adverse drug reaction of the skin): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Levetiracetam and have Cross sensitivity reaction?

- Check whether Cross sensitivity reaction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Levetiracetam:

Levetiracetam (75,292 reports)

Browse all side effects of Levetiracetam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cross sensitivity reaction:

Cross sensitivity reaction (48 drugs)

Browse all the conditions that are associated with Cross sensitivity reaction:

Cross sensitivity reaction (139 conditions)

Related publications that referenced our studies

Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on levetiracetam (the active ingredients of Levetiracetam) and Levetiracetam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.